Moss, MD, Ronald B., Fiona Carleton, PhD, Charles P. Lollo, PhD, and Dennis J. Carlo, PhD. “An Open-Label, Randomized, Single-Dose, Two-Period, Two-Treatment Crossover Bioavailability Study Comparing 5 mg/0.5 ML of Intramuscular Naloxone Hydrochloride to 2 mg/0.4 ML Intramuscular Naloxone Hydrochloride Autoinjector in Healthy Subjects”. Journal of Opioid Management 16, no. 3 (May 1, 2020): 209–214. Accessed May 4, 2024. https://wmpllc.org/ojs/index.php/jom/article/view/2747.